← FDA Drug Approvals (Drugs@FDA)
RESERPINE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 1984-05-01
Drug application
- FDA Application #
ANDA088200- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RESERPINE AND HYDROCHLOROTHIAZIDE
- Generic name
- Hydrochlorothiazide
- Active ingredients
- HYDROCHLOROTHIAZIDE; RESERPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SANDOZ
- First approval
- 1984-05-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown